具有不同温度敏感性的冷适应SARS-CoV-2变异株表现出减毒表型并赋予保护性免疫
研究在Vero细胞低温连续传代获得两株冷适应SARS-CoV-2变异株D-B4和D-D2,经鼻感染叙利亚金黄地鼠评估毒力、免疫原性和保护活性。两株均不引起体重下降、组织病毒滴度和RNA浓度显著低于亲本D株、肺部炎症病变较轻;单次鼻内免疫可诱导中和抗体并保护地鼠免受D株感染和重症肺炎。D-B4无温度敏感表型但丧失感染人肺细胞Calu-3的能力,提示冷适应表型、温度敏感表型和物种特异性改变均为减毒潜在表型标志。
要点
- 冷适应变异株D-B4和D-D2在地鼠中毒力降低,不引起体重下降且组织病毒载量低于D株。
- 单次鼻内免疫D-B4或D-D2可诱导中和抗体,保护地鼠免受D株感染和重症肺炎。
- D-B4无温度敏感表型但丧失感染Calu-3细胞能力,仍表现减毒,提示减毒标志不限于温度敏感表型。
核心结论
- 冷适应SARS-CoV-2变异株D-B4和D-D2在叙利亚金黄地鼠中表现减毒表型并诱导保护性免疫。
- 冷适应表型、温度敏感表型和物种特异性改变是冷适应SARS-CoV-2变异株减毒的潜在表型标志。
- SARS-CoV-2冷适应是开发减毒活COVID-19疫苗的策略,具有较大潜力。
研究设计与样本
- 将Dubrovka(D)株在Vero细胞中低温长期传代获得冷适应变异株Dubrovka-ca-B4(D-B4)和Dubrovka-ca-D2(D-D2)。
- 在叙利亚金黄地鼠(Mesocricetus auratus)经鼻感染模型中评估变异株的毒力、免疫原性和保护活性。
主要发现
- 感染冷适应变异株的动物未见体重下降,组织病毒滴度和病毒RNA浓度显著低于D株,肺部炎症病变较D株轻。
- 单次鼻内免疫D-B4或D-D2可在地鼠中诱导中和抗体产生,并保护其免受D株感染和重症肺炎发生。
- D-B4变异株不具有温度敏感表型,但丧失了感染人肺细胞Calu-3的能力,在地鼠中仍表现毒力降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As novel SARS-CoV-2 Variants of Concern emerge, the efficacy of existing vaccines against COVID-19 is declining. A possible solution to this problem lies in the development of a live attenuated vaccine potentially able of providing cross-protective activity against a wide range of SARS-CoV-2 antigenic variants. Cold-adapted (ca) SARS-CoV-2 variants, Dubrovka-ca-B4 (D-B4) and Dubrovka-ca-D2 (D-D2), were obtained after long-term passaging of the Dubrovka (D) strain in Vero cells at reduced temperatures. Virulence, immunogenicity, and protective activity of SARS-CoV-2 variants were evaluated in experiments on intranasal infection of Syrian golden hamsters (Mesocricetus auratus). In animal model infecting with ca variants, the absence of body weight loss, the significantly lower viral titer and viral RNA concentration in animal tissues, the less pronounced inflammatory lesions in animal lungs as compared with the D strain indicated the reduced virulence of the virus variant. Single intranasal immunization with D-B4 and D-D2 variants induced the production of neutralizing antibodies in hamsters and protected them from infection with the D strain and the development of severe pneumonia. It was shown that for ca SARS-CoV-2 variants, the temperature-sensitive (ts) phenotype was not obligate for virulence reduction. Indeed, the D-B4 variant, which did not possess the ts phenotype but had lost the ability to infect human lung cells Calu-3, exhibited reduced virulence in hamsters. Consequently, the potential phenotypic markers of attenuation of ca SARS-CoV-2 variants are the ca phenotype, the ts phenotype, and the change in species specificity of the virus. This study demonstrates the great potential of SARS-CoV-2 cold adaptation as a strategy to develop a live attenuated COVID-19 vaccine.
引用
- Faizuloev E, Gracheva A, Korchevaya E, et al. Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity. Vaccine. 2022. PMID: 36528447. doi:10.1016/j.vaccine.2022.12.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。